POLYGYNAX (Neomycin sulphate/Polymyxin B sulphate/Nystatin)
₦49,000.00
POLYGYNAX is a combination antimicrobial formulation that includes neomycin sulfate, polymyxin B sulfate, and nystatin. This combination is designed for the treatment of various local infections, particularly in gynecological settings.
Key Features:
- Indications:
- Treatment of mixed bacterial and fungal infections, especially in gynecological or obstetric contexts.
- Effective against conditions such as vulvovaginitis caused by susceptible organisms.
- Active Ingredients:
- Neomycin Sulfate: An aminoglycoside antibiotic effective against a range of gram-negative and some gram-positive bacteria.
- Polymyxin B Sulfate: A polypeptide antibiotic effective against gram-negative bacteria, particularly Pseudomonas aeruginosa.
- Nystatin: An antifungal medication effective against yeast infections, especially those caused by Candida species.
- Dosage Form: Typically available as a vaginal capsule or cream for local application.
Usage:
- Dosage: Follow the prescribed dosage from your healthcare provider. The usual regimen involves administering one capsule or applying the cream daily for a specified duration, typically up to 12 days.
- Administration:
- For vaginal capsules, insert the capsule deeply into the vagina.
- For cream formulations, apply as directed to the affected area.
Precautions:
- Allergies: Inform your healthcare provider if you have a history of allergies to any of the active ingredients or related compounds.
- Side Effects: Possible side effects may include local irritation, allergic reactions, or gastrointestinal disturbances. Any severe or persistent reactions should be reported immediately.
Storage: Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
- Very secured payment methods
- Shipping will be calculated on checkout
- Please note that price may increase due to exchange rate, ensure updated price before making payment
Dispensing supervised byPharm. Tope Kareem, B.PharmPCN Reg. 023669
Last updated 28 August 2026How we write and check this informationPCN Premises Licence LAG20247B39C9





Reviews
There are no reviews yet.